Comments
Loading...
Moleculin Biotech (MBRX) Forecast
NewsEarningsMoleculin Biotech (MBRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMoleculin Biotech (NASDAQ:MBRX) Stock Quotes, Forecast and News Summary
Moleculin Biotech Stock (NASDAQ: MBRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Moleculin Biotech (MBRX) stock?
You can purchase shares of Moleculin Biotech (NASDAQ:MBRX) through any online brokerage.
Who are Moleculin Biotech (MBRX) competitors?
Other companies in Moleculin Biotech’s space includes: NKGen Biotech (NASDAQ:NKGN), Galecto (NASDAQ:GLTO), Alzamend Neuro (NASDAQ:ALZN), Addex Therapeutics (NASDAQ:ADXN) and Coeptis Therapeutics (NASDAQ:COEP).
What is the forecast, or price target, for Moleculin Biotech (MBRX) stock?
Moleculin Biotech has a consensus price target of $14.00.
What is the current price for Moleculin Biotech (MBRX)?
The stock price for Moleculin Biotech (NASDAQ: MBRX) is $2.77 last updated November 14, 2024 at 10:03 AM EST.
Does Moleculin Biotech (MBRX) pay a dividend?
There are no upcoming dividends for Moleculin Biotech.
When is Moleculin Biotech (NASDAQ:MBRX) reporting earnings?
Moleculin Biotech’s Q3 earnings are confirmed for Friday, November 8, 2024.
Is Moleculin Biotech (MBRX) going to split?
There is no upcoming split for Moleculin Biotech.
What sector and industry does Moleculin Biotech (MBRX) operate in?
Moleculin Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.